Abstract

TOFACITINIB IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA-A REVIEW

Reshma Ramesan* and Dr. Sruthy Renjan

.

Abstract

After the arrival of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the irruption of coronavirus sickness 2019 (COVID- 19) commenced across the planet. Understanding the Immunopathogenesis of COVID-19 is crucial for interrupting infectious agent infectivity and preventing aberrant immune responses before vaccination are often developed. It would have general complications and cytokine release syndrome is one among the foremost dangerous complications. many anti-cytokine medication are projected to manage this complication. However, the results of irregular trials are inconsistent and its place within the treatment of COVID-19 is however to be established.

Keywords: .